Baker Avenue Asset Management, LP Bristol Myers Squibb CO Transaction History

Baker Avenue Asset Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $10,072 - $11,263	-174 Reduced 10.77%	1,441 $83,000
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $30,708 - $34,096	482 Added 42.54%	1,615 $103,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $11,696 - $13,266	178 Added 18.64%	1,133 $78,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $65,398 - $77,440	955 New	955 $68,000
Q2 2022 Aug 03, 2022	BUY	$72.62 - $79.98 $307,545 - $338,715	4,235 Added 59.29%	11,378 $876,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $439,151 - $526,581	7,143 New	7,143 $522,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.